Zuurman M - Search Results

1

Ruxolitinib versus best available therapy in inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): 5-year follow up of a randomised, phase 3b study.

Passamonti F, Palandri F, Saydam G, Callum J, Devos T, Guglielmelli P, Vannucchi AM, Zor E, Zuurman M, Gilotti G, Zhang Y, Griesshammer M. Passamonti F, et al. Among authors: zuurman m. Lancet Haematol. 2022 Jul;9(7):e480-e492. doi: 10.1016/S2352-3026(22)00102-8. Epub 2022 May 18. Lancet Haematol. 2022. PMID: 35597252 Clinical Trial.

2

JAK Inhibition with Ruxolitinib in Patients with COVID-19 and Severe Pneumonia: Multicenter Clinical Experience from a Compassionate Use Program in Italy.

Vannucchi AM, Mortara A, D'Alessio A, Morelli M, Tedeschi A, Festuccia MB, Monforte AD, Capochiani E, Selleri C, Simonetti F, Saracino A, Rapezzi D, Badagliacca MR, Falasca K, Molteni A, Palazzolo R, Schettino G, Bocchia M, Turrini M, Ascierto PA, Zuurman M, Paley C, Coco P, Saglio G. Vannucchi AM, et al. Among authors: zuurman m. J Clin Med. 2021 Aug 23;10(16):3752. doi: 10.3390/jcm10163752. J Clin Med. 2021. PMID: 34442045 Free PMC article.

3

Response to angiotensin-converting enzyme inhibition is selectively blunted by high sodium in angiotensin-converting enzyme DD genotype: evidence for gene-environment interaction in healthy volunteers.

Lely AT, Heerspink HJ, Zuurman M, Visser FW, Kocks MJ, Boomsma F, Navis G. Lely AT, et al. Among authors: zuurman m. J Hypertens. 2010 Dec;28(12):2414-21. doi: 10.1097/HJH.0b013e32833eaf34. J Hypertens. 2010. PMID: 20829712

4

Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy.

Smilde TD, Zuurman MW, Hillege HL, van Veldhuisen DJ, van Gilst WH, van der Steege G, Voors AA, Kors JA, de Jong PE, Navis G. Smilde TD, et al. Am J Hypertens. 2007 Oct;20(10):1097-103. doi: 10.1016/j.amjhyper.2007.04.023. Am J Hypertens. 2007. PMID: 17903694

5

CCR5Delta32 genotype is associated with outcome in type 2 diabetes mellitus.

Muntinghe FL, Gross S, Bakker SJ, Landman GW, van der Harst P, Bilo HJ, Navis G, Zuurman MW. Muntinghe FL, et al. Among authors: zuurman mw. Diabetes Res Clin Pract. 2009 Nov;86(2):140-5. doi: 10.1016/j.diabres.2009.08.013. Epub 2009 Sep 9. Diabetes Res Clin Pract. 2009. PMID: 19744740

6

Low levels of sRAGE are associated with increased risk for mortality in renal transplant recipients.

Gross S, van Ree RM, Oterdoom LH, de Vries AP, van Son WJ, de Jong PE, Navis GJ, Zuurman MW, Bierhaus A, Gans RO, Bakker SJ. Gross S, et al. Among authors: zuurman mw. Transplantation. 2007 Sep 15;84(5):659-63. doi: 10.1097/01.tp.0000280556.16275.2a. Transplantation. 2007. PMID: 17876282

7

CCR5 deletion protects against inflammation-associated mortality in dialysis patients.

Muntinghe FL, Verduijn M, Zuurman MW, Grootendorst DC, Carrero JJ, Qureshi AR, Luttropp K, Nordfors L, Lindholm B, Brandenburg V, Schalling M, Stenvinkel P, Boeschoten EW, Krediet RT, Navis G, Dekker FW. Muntinghe FL, et al. Among authors: zuurman mw. J Am Soc Nephrol. 2009 Jul;20(7):1641-9. doi: 10.1681/ASN.2008040432. Epub 2009 Apr 23. J Am Soc Nephrol. 2009. PMID: 19389855 Free PMC article.

8

Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.

Martens HA, Zuurman MW, de Lange AH, Nolte IM, van der Steege G, Navis GJ, Kallenberg CG, Seelen MA, Bijl M. Martens HA, et al. Among authors: zuurman mw. Ann Rheum Dis. 2009 May;68(5):715-20. doi: 10.1136/ard.2007.085688. Epub 2008 May 26. Ann Rheum Dis. 2009. PMID: 18504288

9

Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation.

Munster JM, van der Bij W, Breukink MB, van der Steege G, Zuurman MW, Hepkema BG, Verschuuren EA, van Son WJ, Seelen MA. Munster JM, et al. Among authors: zuurman mw. Transplantation. 2008 Dec 27;86(12):1857-63. doi: 10.1097/TP.0b013e31819064b8. Transplantation. 2008. PMID: 19104434

10

An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.

Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Zuurman MW, van der Steege G, van Tol A, Dullaart RP; PREVEND Study Group. Borggreve SE, et al. J Clin Endocrinol Metab. 2006 Sep;91(9):3382-8. doi: 10.1210/jc.2005-2322. Epub 2006 May 9. J Clin Endocrinol Metab. 2006. PMID: 16684835

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page